Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Starbucks
SBUX
|
+$382M |
| 2 |
CELG
Celgene Corp
CELG
|
+$329M |
| 3 |
Tesla
TSLA
|
+$261M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$254M |
| 5 |
Intel
INTC
|
+$246M |
Top Sells
| 1 |
Fortive
FTV
|
+$1.15B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$331M |
| 5 |
Amazon
AMZN
|
+$262M |
Sector Composition
| 1 | Technology | 13.89% |
| 2 | Healthcare | 13.88% |
| 3 | Financials | 13.32% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVK
3076
Advent Convertible and Income Fund
AVK
$556M
| $142K | ﹤0.01% |
+11,651
| New | +$142K |
|
3077
B2Gold
BTG
$5.89B
| $142K | ﹤0.01% |
48,689
-231,460
| -83% | -$675K |
|
3078
Marchex
MCHX
$87.5M
| $142K | ﹤0.01% |
53,729
-68,146
| -56% | -$180K |
|
3079
Galmed Pharmaceuticals
GLMD
$8.49M
| $141K | ﹤0.01% |
115
-1,719
| -94% | -$2.11M |
|
|
ORBC
3080
DELISTED
ORBCOMM, Inc.
ORBC
| $141K | ﹤0.01% |
17,062
-503,787
| -97% | -$4.16M |
|
3081
Inovio Pharmaceuticals
INO
$141M
| $140K | ﹤0.01% |
2,914
-2,556
| -47% | -$123K |
|
|
SVM
3082
Silvercorp Metals
SVM
$1.13B
| $139K | ﹤0.01% |
66,246
+41,354
| +166% | +$86.8K |
|
|
ETTX
3083
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $139K | ﹤0.01% |
34,143
-45,294
| -57% | -$184K |
|
|
FTD
3084
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $139K | ﹤0.01% |
94,165
-184,066
| -66% | -$272K |
|
3085
BlackRock Credit Allocation Income Trust
BTZ
$1.04B
| $138K | ﹤0.01% |
12,340
-5,906
| -32% | -$66K |
|
3086
Microvision
MVIS
$346M
| $138K | ﹤0.01% |
227,923
-206,387
| -48% | -$125K |
|
3087
ImmunityBio
IBRX
$2.45B
| $137K | ﹤0.01% |
118,066
-7,375
| -6% | -$8.56K |
|
3088
Ribbon Communications
RBBN
$699M
| $137K | ﹤0.01% |
28,463
-60,922
| -68% | -$293K |
|
3089
First Majestic Silver
AG
$5.08B
| $136K | ﹤0.01% |
23,006
-35,505
| -61% | -$210K |
|
3090
BioLife Solutions
BLFS
$1.27B
| $136K | ﹤0.01% |
11,318
-201,892
| -95% | -$2.43M |
|
3091
HireQuest
HQI
$133M
| $135K | ﹤0.01% |
36,321
-6,435
| -15% | -$23.9K |
|
|
ZEPP
3092
Zepp Health
ZEPP
$719M
| $135K | ﹤0.01% |
3,442
-10,133
| -75% | -$397K |
|
|
AAC
3093
DELISTED
AAC Holdings, Inc.
AAC
| $135K | ﹤0.01% |
96,496
-211,717
| -69% | -$296K |
|
|
GLO
3094
Clough Global Opportunities Fund
GLO
$241M
| $134K | ﹤0.01% |
16,300
+5,980
| +58% | +$49.2K |
|
|
ARDS
3095
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
| $134K | ﹤0.01% |
12,112
-11,473
| -49% | -$127K |
|
|
IO
3096
DELISTED
ION Geophysical Corporation
IO
| $132K | ﹤0.01% |
+25,388
| New | +$132K |
|
|
ETJ
3097
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$609M
| $130K | ﹤0.01% |
+16,045
| New | +$130K |
|
|
TOUR
3098
Tuniu
TOUR
$107M
| $128K | ﹤0.01% |
26,349
-8,888
| -25% | -$43.2K |
|
|
PLYM
3099
Plymouth Industrial REIT
PLYM
$988M
| $127K | ﹤0.01% |
10,102
-15,011
| -60% | -$189K |
|
|
CHI
3100
Calamos Convertible Opportunities and Income Fund
CHI
$827M
| $126K | ﹤0.01% |
+14,200
| New | +$126K |
|